HK Stock Market Move | E-HOUSE ENT (02048) surged over 46% in the afternoon as debt restructuring approaches resolution, with the company establishing its core strategy of "AI + Real Estate."
E-House Enterprise Holdings (02048) rose over 46% in the afternoon. As of the time of reporting, it has increased by 34.67% to HKD 0.101, with a trading volume of HKD 13.157 million.
E-HOUSE ENT (02048) surged over 46% in the afternoon. As of the time of writing, it has risen by 34.67%, trading at HKD 0.101, with a transaction volume of HKD 13.157 million.
On the news front, at the meeting held on August 27 regarding the Hong Kong and Cayman plan, 357 plan creditors of E-House, corresponding to claims of approximately USD 648 million, voted in favor of the restructuring plan, representing 97.8% by value of the creditors. Both plans met the required approval threshold. The Hong Kong plan adjudication hearing and the Cayman plan adjudication hearing are scheduled for September 11, 2026, and October 9, 2026, respectively.
It is worth noting that E-House has officially announced its long-term transformation directionmaking AI + Real Estate the core strategy of the company. Through its new brand KerryDeep Intelligence Connection, it aims to seize the new opportunities of the AI era, achieve strategic transformation, and become the strongest AI infrastructure and application service provider in the Chinese real estate sector.
Related Articles
Citibank: Raises the target price for HUTCHMED (00013) to HKD 39, maintaining a Buy/High Risk rating.
HK Stock Market Move | Some innovative pharmaceutical concept stocks have risen. The National Healthcare Security Administration stated that more innovative drugs are expected to be included in medical insurance reimbursement. A national healthcare discussion is about to be held.
HK Stock Market Move | Xiyin-W (00625) fell more than 8%, with a cumulative drop of over 20% in its stock price within four days of listing, resulting in a market value evaporating by over 40 billion Hong Kong dollars.
Citibank: Raises the target price for HUTCHMED (00013) to HKD 39, maintaining a Buy/High Risk rating.
HK Stock Market Move | Some innovative pharmaceutical concept stocks have risen. The National Healthcare Security Administration stated that more innovative drugs are expected to be included in medical insurance reimbursement. A national healthcare discussion is about to be held.
HK Stock Market Move | Xiyin-W (00625) fell more than 8%, with a cumulative drop of over 20% in its stock price within four days of listing, resulting in a market value evaporating by over 40 billion Hong Kong dollars.
RECOMMEND
